ArticlePloS one2026
Effect of exercise preconditioning on myocardial content of Sphingosine1-phosphate and its mechanism in rats after exhaustive exercise.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the effects of exercise preconditioning on rat myocardial Sphingosine1-phosphate(S1P) content and its potential mechanisms of heart protection.
methodsA rat model of exercise preconditioning followed by exhaustive exercise was established. Rats were randomized to four groups: control (C), exercise preconditioning (EP), EP plus the S1PR1-selective antagonist W146 (EP + W146), and EP plus the MEK1/2 inhibitor PD98059 (EP + PD98059). Following a final exhaustive swim, comparisons across groups revealed that EP attenuated myocardial injury and apoptosis, an effect which was abolished by both W146 and PD98059.
results1. Exercise preconditioning (EP) significantly attenuated exhaustive exercise-induced myocardial injury and apoptosis (P < 0.001); 2. EP significantly elevated myocardial S1P levels (P = 0.002), and S1PR1-selective antagonist (W146) abolished this cardioprotective effect (P = 0.016 for apoptosis); 3. Most importantly, MAPK pathway inhibition (PD98059) abrogated the protective effect of EP, as evidenced by significantly increased apoptosis (P = 0.002), despite unaltered S1P levels.
conclusionIn summary, beyond confirming S1P elevation with exercise preconditioning, our findings propose the S1P→MAPK signaling axis as a novel mechanistic pathway warranting future validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.